Polgar Orsolya, Ozvegy-Laczka Csilla, Robey Robert W, Morisaki Kuniaki, Okada Masaki, Tamaki Akina, Koblos Gabriella, Elkind N Barry, Ward Yvona, Dean Michael, Sarkadi Balazs, Bates Susan E
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room 13N240, Bethesda, Maryland 20892, USA.
Biochemistry. 2006 Apr 25;45(16):5251-60. doi: 10.1021/bi0521590.
ABCG2 is an ATP-binding cassette half-transporter conferring resistance to chemotherapeutic agents such as mitoxantrone, irinotecan, and flavopiridol. With its one transmembrane and one ATP-binding domain, ABCG2 is thought to homodimerize for function. One conserved region potentially involved in dimerization is a three-amino acid sequence in transmembrane segment 5 (residues 552-554). Mutations in the corresponding residues in the Drosophila white protein (an orthologue of ABCG2) are thought to disrupt heterodimerization. We substituted glycine 553 with leucine (G553L) followed by stable transfection in HEK 293 cells. The mutant was not detectable on the cell surface, and markedly reduced protein expression levels were observed by immunoblotting. A deficiency in N-linked glycosylation was suggested by a reduction in molecular mass compared to that of the 72 kDa wild-type ABCG2. Similar results were observed with the G553E mutant. Confocal microscopy demonstrated mostly ER localization of the G553L mutant in HEK 293 cells, even when coexpressed with the wild-type protein. Despite its altered localization, the G553L and G553E mutants were cross-linked using amine-reactive cross-linkers with multiple arm lengths, suggesting that the monomers are in the proximity of each other but are unable to complete normal trafficking. Interestingly, when expressed in Sf9 insect cells, G553L moves to the cell membrane but is unable to hydrolyze ATP or transport the Hoechst dye. Still, when coexpressed, the mutant interferes with the Hoechst transport activity of the wild-type protein. These data show that glycine 553 is important for protein trafficking and are consistent with, but do not yet prove, its involvement in ABCG2 homodimerization.
ABCG2是一种ATP结合盒式半转运蛋白,赋予细胞对米托蒽醌、伊立替康和黄酮哌啶醇等化疗药物的抗性。ABCG2具有一个跨膜结构域和一个ATP结合结构域,其功能被认为依赖于同源二聚体的形成。一个可能参与二聚化的保守区域是跨膜片段5中的一个三氨基酸序列(第552 - 554位残基)。果蝇白色蛋白(ABCG2的同源物)中相应残基的突变被认为会破坏异源二聚化。我们将第553位甘氨酸替换为亮氨酸(G553L),随后在HEK 293细胞中进行稳定转染。突变体在细胞表面无法检测到,通过免疫印迹观察到蛋白质表达水平显著降低。与72 kDa的野生型ABCG2相比,分子量的降低提示N - 糖基化存在缺陷。G553E突变体也观察到了类似结果。共聚焦显微镜显示,即使与野生型蛋白共表达,G553L突变体在HEK 293细胞中大多定位于内质网。尽管其定位发生改变,但G553L和G553E突变体仍能使用具有多种臂长的胺反应性交联剂进行交联,这表明单体彼此靠近,但无法完成正常的转运过程。有趣的是,当在Sf9昆虫细胞中表达时,G553L能够移动到细胞膜,但无法水解ATP或转运Hoechst染料。然而,当共表达时,该突变体仍会干扰野生型蛋白的Hoechst转运活性。这些数据表明第553位甘氨酸对蛋白质转运很重要,这与它参与ABCG2同源二聚化的观点一致,但尚未得到证实。